Traws Pharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 730.00 K | $824.90 K | 121.21% | 12.54% |
| 02/17/2026 | 713.54 K | $806.30 K | 100.00% | 12.26% | |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 678.14 K | $766.30 K | 2,280.03% | 11.65% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 605.53 K | $684.25 K | 0.00% | 10.40% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 194.54 K | $219.83 K | 100.00% | 3.34% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 154.43 K | $174.51 K | 100.00% | 2.65% |
| VANGUARD GROUP INC | 01/29/2026 | 87.26 K | $98.60 K | 0.00% | 1.50% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 61.65 K | $69.67 K | 41.93% | 1.06% |
| XTX TOPCO LTD | 02/17/2026 | 42.21 K | $47.70 K | 294.19% | 0.73% |
| STATE STREET CORP | 02/13/2026 | 25.80 K | $29.16 K | 100.00% | 0.44% |
| CITADEL ADVISORS LLC | 02/17/2026 | 24.82 K | $28.05 K | 100.00% | 0.43% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 19.24 K | $21.75 K | -12.60% | 0.33% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 14.20 K | $16.04 K | 100.00% | 0.24% |
| BLACKROCK, INC. | 02/12/2026 | 9.96 K | $11.25 K | 0.00% | 0.17% |
| UBS GROUP AG | 01/29/2026 | 7.72 K | $8.73 K | 128,600.00% | 0.13% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 162 | $183 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 113 | $128 | 10.78% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 8 | $9 | 100.00% | 0.00% |
| FMR LLC | 02/17/2026 | 2 | $2 | 0.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 1 | $1 | -99.97% | 0.00% |
| MORGAN STANLEY | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| ASSETMARK, INC | 01/23/2026 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
| VERMILLION & WHITE WEALTH MANAGEMENT GROUP, LLC | 02/18/2026 | 0 | $0 | -100.00% | 0.00% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Traws Pharma Inc. institutional Ownership - FAQ's
During the previous two years, 22 institutional investors and hedge funds held shares of Traws Pharma Inc.. The most heavily invested institutionals were:
ADAGE CAPITAL PARTNERS GP, L.L.C.: 730,000
ORBIMED ADVISORS LLC: 605,531
BOOTHBAY FUND MANAGEMENT, LLC: 194,536
ADAR1 Capital Management, LLC: 154,431
VANGUARD GROUP INC: 87,259
GEODE CAPITAL MANAGEMENT, LLC: 61,653
3.31% of Traws Pharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.98 M shares in the last 24 months. This purchase volume represents approximately $3.18 M in transactions.